Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2017

View Archived Issues

Fujifilm to begin clinical testing of FF-10832 for advanced solid tumors next year

FDA issues refusal to file letter for SteadyMed's Trevyent NDA

Akcea announces NDA submission for volanesorsen in familial chylomicronemia syndrome

Bayer submits BLA to FDA for BAY-94-9027

Sunovion files NDA for dasotraline to treat ADHD

Daiichi Sankyo terminates agreement with Charleston Laboratories

Topline results from Asian REDUCER trial of mirogabalin in diabetic peripheral neuropathic pain

Sumitomo Dainippon Pharma submits an application in Japan for an additional indication for Trerief

Bristol-Myers Squibb explores adaptor-associated kinase 1 as a target for neuropathic pain

Thermo Fisher forms European Immuno-Oncology Consortium

Serum APEX found a marker of myocarditis severity

European Commission approves pediatric formulation of Mimpara

Mochida compound shows effective targeting of FFAR1 for diabetes

Horizon Discovery completes acquisition of GE Healthcare Dharmacon

Aptevo and MorphoSys end partnership for MOR-209

FDA awards fast track designation to Iovance's LN-144 for advanced melanoma

Taisho Pharmaceutical presents 20-HETE synthase inhibitors

Heptares begins leukotriene receptor modulator collaboration with Juntendo University

ImMAGE Biotherapeutics terminates operations

Roche and Genentech patent new Janus kinase inhibitors

Sprint Bioscience AB divulges PIK3C3 inhibitors

RegeneRx completes license expansion agreement with GtreeBNT for RGN-137

Oragenics initiates phase II trial of AG-013 for oral mucositis

Janssen Vaccines & Prevention BV patent adenoviral vectors for treating malaria

Penn State Research Foundation divulges CCK2 receptor-targeting DNA aptamers

Novel compounds target MYC via G-quadruplex in the promoter region

Janssen Biotech terminates duvortuxizumab agreement with MacroGenics

Novel susceptibility loci identified for aortic aneurysm in Japanese individuals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...